THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Genzyme talks trigger patient jitters

Drug firm nurtured bonds with customers, but what if it is sold?

After 20 years of support, Linda Rubenstein, a Gaucher patient, says the chief executive knows her. “He made it his business to know,’’ she said. After 20 years of support, Linda Rubenstein, a Gaucher patient, says the chief executive knows her. “He made it his business to know,’’ she said. (Dina Rudick/Globe Staff)
By Erin Ailworth
Globe Staff / August 8, 2010

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

Linda Rubenstein puttered around her kitchen, pink earrings flashing as she talked about her social life, her business, her teenage son. (Full article: 965 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass